Skip to main content
25 July 2026
Last updated: Friday 24 July 2026

User account anon menu

  • Login
  • Register and subscribe
Home
  • Home
  • News
    • News
    • Appointments
    • Events
  • About MedNous
    • Who We Are
    • Editorial Board
    • Editorial Policy
  • Research Directory
    • Research Directory
    • Organisations
    • Interviewees
    • Terms
    • Topics
  • Contact Us
    • Contact Form
Menu

Breadcrumb

  1. Home
  2. Targeting New Medicines At Roche

Targeting new medicines at Roche

Sunday 12 January 2014
Interviewee/Contributor
Max Hasmann
Organisation
Roche Group

---Subscribe to MedNous to access this article---

Breast cancer
Antibody Drug Conjugates ADCs
Cancer (Oncology)
Personalised medicine

Select a News Category

  • Clinical Research
  • Company News
  • Finance, Grants, Deals
  • IPR & Legal
  • Regenerative Medicine
  • Regulation & Policy
  • Research & University News

Recent Appointments

ViCentra appoints CFO and adds a board member

Wednesday 22 July 2026

New CEO at Simris Biologics

Wednesday 22 July 2026

New CEO at Genopore

Wednesday 22 July 2026

Camena Bioscience appoints CEO

Wednesday 22 July 2026

Lundbeck promotes research head to EVP R&D

Wednesday 22 July 2026
View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

  • News
  • Industry appointments
  • Events
  • Research directory
  • Subscribe

Footer

  • Privacy policy

© 2026 Evernow Publishing Ltd.

  • Home
  • News
    • News
    • Appointments
    • Events
  • About MedNous
    • Who We Are
    • Editorial Board
    • Editorial Policy
  • Research Directory
    • Research Directory
    • Organisations
    • Interviewees
    • Terms
    • Topics
  • Contact Us
    • Contact Form